" class="no-js "lang="en-US"> Partnerships Archives - Page 45 of 52 - Medtech Alert
Tuesday, September 30, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

Aichi Cancer Center and Fujitsu Limited today announced the development of an AI solution able […]

LovedBy and Dexcom Announce Partnership to Help Adolescent Diabetes Patients

LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]

Applied BioMath, LLC Announces Collaboration with BYOMass™ for Systems Pharmacology Modeling in Oncology

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis […]

Roche Announces PathAI Collaboration for Artificial Intelligence-based Digital Pathology Applications for Improved Patient Care

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with PathAI, […]

MindMaze and The Royal Buckinghamshire Hospital Pioneer First U.K. Location-based Digital Therapeutic Solution for Brain Repair

MindMaze Healthcare, the category leader in the multibillion-dollar digital neurotherapeutics market, today announced the first […]

LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies Announce Collaboration to Support Development and Manufacturing of Gene Therapies for Genetic Diseases

LEXEO Therapeutics, a fully integrated clinical-stage gene therapy company advancing adeno-associated virus (AAV)-mediated treatments for […]

Dotmatics Partners with RockStep Solutions to Provide an Integrated Solution for Digitalized in Vivo Drug Discovery

Dotmatics Ltd, an Insightful Science company that provides leading-edge scientific informatics software to drive the […]

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

Fujitsu Limited today announced that it has started joint clinical research with the University of […]

Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced a non-exclusive clinical collaboration agreement […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more